The DOI matches its Crossref record; 352 of the 352 references it cites were found in a registry or an index.
Emerging insights into the molecular and cellular basis of glioblastoma
Open accessAbstract
Glioblastoma is both the most common and lethal primary malignant brain tumor. Extensive multiplatform genomic characterization has provided a higher-resolution picture of the molecular alterations underlying this disease. These studies provide the emerging view that “glioblastoma” represents several histologically similar yet molecularly heterogeneous diseases, which influences taxonomic classification systems, prognosis, and therapeutic decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–352 of 352
Reifenberger, G., REIFENBERGER, J., Ichimura, K., Meltzer, P. S., & Collins, V. P. (1994) · PubMed · Cited by 279
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
Bajenaru, M. L., Hernandez, M. R., Perry, A., Zhu, Y., Parada, L. F., Garbow, J. R., & Gutmann, D. H. (2003) · PubMed · Cited by 275
Deadly Teamwork: Neural Cancer Stem Cells and the Tumor Microenvironment
Lathia, J. D., Heddleston, J. M., Venere, M., & Rich, J. N. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.013 · Cited by 273
Revisiting the TCA cycle: signaling to tumor formation
Raimundo, N., Baysal, B. E., & Shadel, G. S. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.06.001 · Cited by 271
PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas
Zheng, H., Ying, H., Wiedemeyer, R., Yan, H., Quayle, S. N., Ivanova, E. V., Paik, J.-H., Zhang, H., Xiao, Y., Perry, S. R., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.020 · Cited by 271
Self-citationPten Haploinsufficiency Accelerates Formation of High-Grade Astrocytomas
Kwon, C.-H., Zhao, D., Chen, J., Alcantara, S., Li, Y., Burns, D. K., Mason, R. P., Lee, E. Y.-H. P., Wu, H., & Parada, L. F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6867 · Cited by 270
Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J. A., Heitz, P. U., & Eng, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64624-x · Cited by 266
Jaros, E., Perry, R., Adam, L., Kelly, P., Crawford, P., Kalbag, R., Mendelow, A., Sengupta, R., & Pearson, A. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.273 · Cited by 264
Angiogenesis and invasion in glioma
Onishi, M., Ichikawa, T., Kurozumi, K., & Date, I. (2011) · Brain Tumor Pathology · doi:10.1007/s10014-010-0007-z · Cited by 264
Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic Astrocytoma
Bar, E. E., Lin, A., Tihan, T., Burger, P. C., & Eberhart, C. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181845622 · Cited by 261
Guryanova, O. A., Wu, Q., Cheng, L., Lathia, J. D., Huang, Z., Yang, J., MacSwords, J., Eyler, C. E., McLendon, R. E., Heddleston, J. M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.004 · Cited by 260
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors
De Raedt, T., Walton, Z., Yecies, J. L., Li, D., Chen, Y., Malone, C. F., Maertens, O., Jeong, S. M., Bronson, R. T., Lebleu, V., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.014 · Cited by 258
Pathways Mediating Resistance to Vascular Endothelial Growth Factor–Targeted Therapy
Ellis, L. M., & Hicklin, D. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5287 · Cited by 257
Wang, Y., Yang, J., Zheng, H., Tomasek, G. J., Zhang, P., McKeever, P. E., Lee, E. Y.-H. P., & Zhu, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.001 · Cited by 250
BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma
Hawkins, C., Walker, E., Mohamed, N., Zhang, C., Jacob, K., Shirinian, M., Alon, N., Kahn, D., Fried, I., Scheinemann, K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0034 · Cited by 250
Novel anti-angiogenic therapies for malignant gliomas
Norden, A. D., Drappatz, J., & Wen, P. Y. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70260-6 · Cited by 246
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Wakimoto, H., Mohapatra, G., Kanai, R., Curry, W. T., Yip, S., Nitta, M., Patel, A. P., Barnard, Z. R., Stemmer-Rachamimov, A. O., Louis, D. N., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor195 · Cited by 244
NFKBIA Deletion in Glioblastomas
Bredel, M., Scholtens, D. M., Yadav, A. K., Alvarez, A. A., Renfrow, J. J., Chandler, J. P., Yu, I. L. Y., Carro, M. S., Dai, F., Tagge, M. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006312 · Cited by 243
Non-Stem Cell Origin for Oligodendroglioma
Persson, A. I., Petritsch, C., Swartling, F. J., Itsara, M., Sim, F. J., Auvergne, R., Goldenberg, D. D., Vandenberg, S. R., Nguyen, K. N., Yakovenko, S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.033 · Cited by 242
The Principles of Pathologic Histology
Mallory, F. B. (1915) · Southern Medical Journal · doi:10.1097/00007611-191502000-00032 · Cited by 236
Molecular subclassification of diffuse gliomas: Seeing order in the chaos
Huse, J. T., Phillips, H. S., & Brennan, C. W. (2011) · Glia · doi:10.1002/glia.21165 · Cited by 233
Self-citationDu, J., Bernasconi, P., Clauser, K. R., Mani, D. R., Finn, S. P., Beroukhim, R., Burns, M., Julian, B., Peng, X. P., Hieronymus, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1513 · Cited by 232
Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis
Zhu, H., Acquaviva, J., Ramachandran, P., Boskovitz, A., Woolfenden, S., Pfannl, R., Bronson, R. T., Chen, J. W., Weissleder, R., Housman, D. E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813314106 · Cited by 231
PTEN Signaling pathways in glioblastoma
Koul, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6954 · Cited by 228
Asymmetry-Defective Oligodendrocyte Progenitors Are Glioma Precursors
Sugiarto, S., Persson, A. I., Munoz, E. G., Waldhuber, M., Lamagna, C., Andor, N., Hanecker, P., Ayers-Ringler, J., Phillips, J., Siu, J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.011 · Cited by 225
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
Wiedemeyer, W. R., Dunn, I. F., Quayle, S. N., Zhang, J., Chheda, M. G., Dunn, G. P., Zhuang, L., Rosenbluh, J., Chen, S., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001613107 · Cited by 223
Self-citationFang, M., Shen, Z., Huang, S., Zhao, L., Chen, S., Mak, T. W., & Wang, X. (2010) · Cell · doi:10.1016/j.cell.2010.10.010 · Cited by 222
Distinct Transcription Profiles of Primary and Secondary Glioblastoma Subgroups
Tso, C.-L., Freije, W. A., Day, A., Chen, Z., Merriman, B., Perlina, A., Lee, Y., Dia, E. Q., Yoshimoto, K., Mischel, P. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-0077 · Cited by 221
Liu, Q., Wang, J., Kang, S. A., Thoreen, C. C., Hur, W., Ahmed, T., Sabatini, D. M., & Gray, N. S. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101520v · Cited by 219
The retinoblastoma gene is involved in malignant progression of astrocytomas
Henson, J. W., Schnitker, B. L., Correa, K. M., von Deimling, A., Fassbender, F., Xu, H., Benedict, W. F., Yandell, D. W., & Louis, D. N. (1994) · Annals of Neurology · doi:10.1002/ana.410360505 · Cited by 217
PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
Ozawa, T., Brennan, C. W., Wang, L., Squatrito, M., Sasayama, T., Nakada, M., Huse, J. T., Pedraza, A., Utsuki, S., Yasui, Y., et al. (2010) · Genes & Development · doi:10.1101/gad.1972310 · Cited by 217
Self-citationRadiographic patterns of relapse in glioblastoma
Chamberlain, M. C. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0251-4 · Cited by 215
Biology of Angiogenesis and Invasion in Glioma
Tate, M. C., & Aghi, M. K. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.04.001 · Cited by 213
Boerner, J. L., Demory, M. L., Silva, C., & Parsons, S. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7059-7071.2004 · Cited by 213
Analysis of the activation status of Akt, NFκB, and Stat3 in human diffuse gliomas
Wang, H., Wang, H., Zhang, W., Huang, H. J., Liao, W. S. L., & Fuller, G. N. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700123 · Cited by 212
Maher, E. A., Brennan, C., Wen, P. Y., Durso, L., Ligon, K. L., Richardson, A., Khatry, D., Feng, B., Sinha, R., Louis, D. N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2072 · Cited by 210
Self-citationVEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
Gerstner, E. R., Duda, D. G., di Tomaso, E., Ryg, P. A., Loeffler, J. S., Sorensen, A. G., Ivy, P., Jain, R. K., & Batchelor, T. T. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.14 · Cited by 208
Davis, F. G., Kupelian, V. A., Freels, S. A., McCarthy, B. J., & Surawicz, T. S. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.3.152 · Cited by 204
Future medical applications of single-cell sequencing in cancer
Navin, N., & Hicks, J. (2011) · Genome Medicine · doi:10.1186/gm247 · Cited by 199
An in vivo patient-derived model of endogenous IDH1-mutant glioma
Luchman, H. A., Stechishin, O. D., Dang, N. H., Blough, M. D., Chesnelong, C., Kelly, J. J., Nguyen, S. A., Chan, J. A., Weljie, A. M., Cairncross, J. G., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nor207 · Cited by 198
Amplification of Epidermal Growth Factor Receptor Gene in Gliomas: Histopathology and Prognosis
Hurt, M. R., Moossy, J., Donovan-Peluso, M., & Locker, J. (1992) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199201000-00010 · Cited by 197
Sirko, S., von Holst, A., Wizenmann, A., Götz, M., & Faissner, A. (2007) · Development · doi:10.1242/dev.02871 · Cited by 196
IDH2 Mutations in Patients with d -2-Hydroxyglutaric Aciduria
Kranendijk, M., Struys, E. A., van Schaftingen, E., Gibson, K. M., Kanhai, W. A., van der Knaap, M. S., Amiel, J., Buist, N. R., Das, A. M., de Klerk, J. B., et al. (2010) · Science · doi:10.1126/science.1192632 · Cited by 195
Daginakatte, G. C., & Gutmann, D. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm059 · Cited by 193
A Network Model of a Cooperative Genetic Landscape in Brain Tumors
Bredel, M., Scholtens, D. M., Harsh, G. R., Bredel, C., Chandler, J. P., Renfrow, J. J., Yadav, A. K., Vogel, H., Scheck, A. C., Tibshirani, R., et al. (2009) · JAMA · doi:10.1001/jama.2009.997 · Cited by 192
mTOR signaling in glioblastoma: lessons learned from bench to bedside
Akhavan, D., Cloughesy, T. F., & Mischel, P. S. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq052 · Cited by 191
Wang, S.-C., & Hung, M.-C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2813 · Cited by 190
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Verhoeff, J. J., van Tellingen, O., Claes, A., Stalpers, L. J., van Linde, M. E., Richel, D. J., Leenders, W. P., & van Furth, W. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-444 · Cited by 189
Wang, H., Wang, H., Shen, W., Huang, H. J., Hu, L., Ramdas, L., Zhou, Y., Liao, W. S. ‐., Fuller, G. N., & Zhang, W. (2003) · PubMed · Cited by 189
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
Self-citationPrognostic significance of c‐Met expression in glioblastomas
Kong, D., Song, S., Kim, D., Joo, K. M., Yoo, J., Koh, J. S., Dong, S. M., Suh, Y., Lee, J., Park, K., et al. (2009) · Cancer · doi:10.1002/cncr.23972 · Cited by 187
Whiteman, D. C., Zhou, X., Cummings, M. C., Pavey, S., Hayward, N. K., & Eng, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10294 · Cited by 187
Song, H., Li, Y., Lee, J., Schwartz, A. L., & Bu, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3379 · Cited by 186
EGFR Signals to mTOR Through PKC and Independently of Akt in Glioma
Fan, Q.-W., Cheng, C., Knight, Z. A., Haas-Kogan, D., Stokoe, D., James, C. D., McCormick, F., Shokat, K. M., & Weiss, W. A. (2009) · Science Signaling · doi:10.1126/scisignal.2000014 · Cited by 186
Zhou, X.-P., Loukola, A., Salovaara, R., Nystrom-Lahti, M., Peltomäki, P., de la Chapelle, A., Aaltonen, L. A., & Eng, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64200-9 · Cited by 185
Dai, B., Kang, S.-H., Gong, W., Liu, M., Aldape, K. D., Sawaya, R., & Huang, S. (2007) · Oncogene · doi:10.1038/sj.onc.1210443 · Cited by 174
The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
Von Deimling, A., Korshunov, A., & Hartmann, C. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00454.x · Cited by 174
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
Quant, E. C., Norden, A. D., Drappatz, J., Muzikansky, A., Doherty, L., LaFrankie, D., Ciampa, A., Kesari, S., & Wen, P. Y. (2009) · Neuro-Oncology · doi:10.1215/15228517-2009-006 · Cited by 173
Agnihotri, S., Gajadhar, A. S., Ternamian, C., Gorlia, T., Diefes, K. L., Mischel, P. S., Kelly, J., McGown, G., Thorncroft, M., Carlson, B. L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59334 · Cited by 172
High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4229 · Cited by 171
EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway
Bonavia, R., Inda, M. M., Vandenberg, S., Cheng, S.-Y., Nagane, M., Hadwiger, P., Tan, P., Sah, D. W. Y., Cavenee, W. K., & Furnari, F. B. (2012) · Oncogene · doi:10.1038/onc.2011.563 · Cited by 170
Self-citationProteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis
McGillicuddy, L. T., Longo, J. F., Hollstein, P. E., Kubek, S., Beroukhim, R., Raedt, T. D., Johnson, B. W., Williams, S. M. G., Nghiemphu, P. L., Liau, L. M., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.009 · Cited by 170
Self-citationPTEN is destabilized by phosphorylation on Thr366
Maccario, H., Perera, N. M., Davidson, L., Downes, C. P., & Leslie, N. R. (2007) · Biochemical Journal · doi:10.1042/bj20061837 · Cited by 169
Somatic alterations in the human cancer genome
Weir, B., Zhao, X., & Meyerson, M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.11.004 · Cited by 166
Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies
Hamer, P. C. D. W. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop068 · Cited by 166
Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga, K., Todaka, T., Morioka, M., Hamada, J., Kai, Y., Yano, S., Okamura, A., Takakura, N., Suda, T., & Ushio, Y. (2001) · PubMed · Cited by 166
Pandey, A., Lazar, D. F., Saltiel, A. R., & Dixit, V. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43790-8 · Cited by 164
PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma
Molina, J. R., Agarwal, N. K., Morales, F. C., Hayashi, Y., Aldape, K. D., Cote, G., & Georgescu, M.-M. (2012) · Oncogene · doi:10.1038/onc.2011.324 · Cited by 162
Kaelin, W. G. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010975 · Cited by 161
A Review of VEGF/VEGFR-Targeted Therapeutics for Recurrent Glioblastoma
Reardon, D. A., Turner, S., Peters, K. B., Desjardins, A., Gururangan, S., Sampson, J. H., McLendon, R. E., Herndon, J. E., Jones, L. W., Kirkpatrick, J. P., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0038 · Cited by 161
PIK3CA Gene Mutations in Pediatric and Adult Glioblastoma Multiforme
Gallia, G. L., Rand, V., Siu, I.-M., Eberhart, C. G., James, C. D., Marie, S. K. N., Oba-Shinjo, S. M., Carlotti, C. G., Caballero, O. L., Simpson, A. J. G., et al. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0172 · Cited by 161
Mechanisms of angiogenesis in gliomas
Kargiotis, O., Rao, J., & Kyritsis, A. P. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9097-6 · Cited by 158
NG2+/Olig2+ Cells are the Major Cycle‐Related Cell Population of the Adult Human Normal Brain
Geha, S., Pallud, J., Junier, M., Devaux, B. C., Léonard, N., Chassoux, F., Chneiweiss, H., Daumas‐Duport, C., & Varlet, P. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00295.x · Cited by 158
Lu, K. V., Zhu, S., Cvrljevic, A., Huang, T. T., Sarkaria, S., Ahkavan, D., Dang, J., Dinca, E. B., Plaisier, S. B., Oderberg, I., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0347 · Cited by 158
Self-citationBrain tumor stem cells: The cancer stem cell hypothesis writ large
Dirks, P. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.08.001 · Cited by 156
Sun, M., Hillmann, P., Hofmann, B. T., Hart, J. R., & Vogt, P. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009652107 · Cited by 155
The Growth of Glioblastoma Multiforme (Astrocytomas, Grades 3 and 4) in Neurosurgical Practice
Matsukado, Y., MacCarty, C. S., & Kernohan, J. W. (1961) · Journal of neurosurgery · doi:10.3171/jns.1961.18.5.0636 · Cited by 154
Horbinski, C., Hamilton, R. L., Nikiforov, Y. E., & Pollack, I. F. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0634-9 · Cited by 153
Integrins: Molecular determinants of glioma invasion
D’Abaco, G. M., & Kaye, A. H. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.06.019 · Cited by 153
Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas
Biernat, W., Huang, H., Yokoo, H., Kleihues, P., & Ohgaki, H. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00045.x · Cited by 152
Pore, N., Liu, S., Haas-Kogan, D. A., O’Rourke, D. M., & Maity, A. M. (2003) · PubMed · Cited by 151
Engagement of CD44 Promotes Rac Activation and CD44 Cleavage during Tumor Cell Migration
Murai, T., Miyazaki, Y., Nishinakamura, H., Sugahara, K. N., Miyauchi, T., Sako, Y., Yanagida, T., & Miyasaka, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307356200 · Cited by 148
PTEN-Mediated Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors
Mellinghoff, I. K., Cloughesy, T. F., & Mischel, P. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1992 · Cited by 146
Hyaluronate Receptors Mediating Glioma Cell Migration and Proliferation
Akiyama, Y., Jung, S., Salhia, B., Lee, S., Hubbard, S.-L., Taylor, M. D., Mainprize, T. G., Akaishi, K., van Furth, W. R., & Rutka, J. T. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1012297132047 · Cited by 139
Genetic Alterations of Phosphoinositide 3‐kinase Subunit Genes in Human Glioblastomas
Mizoguchi, M., Nutt, C. L., Mohapatra, G., & Louis, D. N. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00080.x · Cited by 136
Levin, V. A., Phuphanich, S., Yung, W. K. A., Forsyth, P. A., Maestro, R. F. D., Perry, J., Fuller, G. N., & Baillet, M. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-9098-5 · Cited by 130
Expression of Multidrug Resistance Genes in Normal and Cancer Stem Cells
Shervington, A. A., & Lu, C. (2008) · Cancer Investigation · doi:10.1080/07357900801904140 · Cited by 129
Kotliarov, Y., Steed, M. E., Christopher, N., Walling, J., Su, Q., Heiss, J. D., Rosenblum, M., Mikkelsen, T., Zenklusen, J. C., & Fine, H. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1691 · Cited by 127
Pillay, V., Allaf, L., Wilding, A. L., Donoghue, J. F., Court, N. W., Greenall, S. A., Scott, A. M., & Johns, T. G. (2009) · Neoplasia · doi:10.1593/neo.09230 · Cited by 126
Immunohistochemical analysis of the mutant epidermal growth factor, ΔEGFR, in glioblastoma
Nishikawa, R., Sugiyama, T., Narita, Y., Furnari, F. B., Cavenee, W. K., & Matsutani, M. (2004) · Brain Tumor Pathology · doi:10.1007/bf02484510 · Cited by 126
Self-citationSmith, J. S., Wang, X.-Y., Qian, J., Hosek, S. M., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.6.495 · Cited by 125
A human brain tumor-derived PDGFR-α deletion mutant is transforming
Clarke, I. D., & Dirks, P. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206160 · Cited by 124
Platelet-derived Growth Factor and Its Receptor Expression in Human Oligodendrogliomas
Rocco, F. D., Carroll, R. S., Zhang, J., & Black, P. M. (1998) · Neurosurgery · doi:10.1097/00006123-199802000-00080 · Cited by 123
Reardon, D. A., Neyns, B., Weller, M., Tonn, J. C., Nabors, B., & Stupp, R. (2011) · Future Oncology · doi:10.2217/fon.11.8 · Cited by 122
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Gallia, G. L., Tyler, B., Hann, C. L., Siu, I., Giranda, V. L., Vescovi, A. L., Brem, H., & Riggins, G. J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0680 · Cited by 121
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development
Wiedemeyer, R., Brennan, C., Heffernan, T. P., Xiao, Y., Mahoney, J. E., Protopopov, A. I., Zheng, H., Bignell, G. R., Furnari, F. B., Cavenee, W. K., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.010 · Cited by 118
Self-citationBello, L., Lucini, V., Carrabba, G. G., Giussani, C. G., Machluf, M., Pluderi, M., Nikas, D. L., Zhang, J., Tomei, G., Villani, R. M., et al. (2001) · PubMed · Cited by 115
Soroceanu, L., Kharbanda, S., Chen, R., Soriano, R. H., Aldape, K., Misra, A., Zha, J., Forrest, W. F., Nigro, J. M., Modrusan, Z. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611271104 · Cited by 114
Amplification and differential expression of members of theerbB-gene family in human glioblastoma
Schlegel, J., Stumm, G., Br�ndle, K., Merdes, A., Mechtersheimer, G., Hynes, N. E., & Kiessling, M. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052920 · Cited by 112
Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells
Sunayama, J., Satō, A., Matsuda, K., Tachibana, K., Suzuki, K., Narita, Y., Shibui, S., Sakurada, K., Kayama, T., Tomiyama, A., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq103 · Cited by 112
A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG
Pietrak, B., Zhao, H., Qi, H., Quinn, C. J., Gao, E. N., Boyer, J. G., Concha, N. O., Brown, K., Duraiswami, C., Wooster, R. F., et al. (2011) · Biochemistry · doi:10.1021/bi200499m · Cited by 112
Lyn Kinase Activity Is the Predominant Cellular Src Kinase Activity in Glioblastoma Tumor Cells
Stettner, M. R., Wang, W., Nabors, B., Bharara, S., Flynn, D. C., Grammer, J. R., Gillespie, G. Y., & Gladson, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3688 · Cited by 111
Chi, A. S., Batchelor, T. T., Kwak, E. L., Clark, J. W., Wang, D. L., Wilner, K. D., Louis, D. N., & Iafrate, A. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4586 · Cited by 110
Cyclic AMP Suppression Is Sufficient to Induce Gliomagenesis in a Mouse Model of Neurofibromatosis-1
Warrington, N. M., Gianino, S. M., Jackson, E. N., Goldhoff, P., Garbow, J. R., Piwnica-Worms, D. R., Gutmann, D. H., & Rubin, J. B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3769 · Cited by 109
Vivanco, I., Rohle, D., Versele, M., Iwanami, A., Kuga, D., Oldrini, B., Tanaka, K., Dang, J. H. T., Kubek, S., Palaskas, N. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911188107 · Cited by 108
Self-citationIntegration and analysis of genome-scale data from gliomas
Riddick, G., & Fine, H. A. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.100 · Cited by 105
Banerjee, S., Crouse, N. R., Emnett, R. J., Gianino, S. M., & Gutmann, D. H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019012108 · Cited by 105
RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
Sohr, S., & Engeland, K. (2008) · Cell Cycle · doi:10.4161/cc.7.21.7014 · Cited by 104
Involvement of endothelial progenitor cells in tumor vascularization
Patenaude, A., Parker, J., & Karsan, A. (2010) · Microvascular Research · doi:10.1016/j.mvr.2010.01.007 · Cited by 103
PIK3CA alterations in primary (de novo) and secondary glioblastomas
Kita, D., Yonekawa, Y., Weller, M., & Ohgaki, H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0186-1 · Cited by 100
Ziegler, D. S., Wright, R. D., Kesari, S., Lemieux, M. E., Tran, M. A., Jain, M., Zawel, L. S., & Kung, A. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34120 · Cited by 100
Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
Reznik, T. E., Sang, Y., Ma, Y., Abounader, R., Rosen, E. M., Xia, S., & Laterra, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0236 · Cited by 94
PI3Kinase signaling in glioblastoma
Lino, M. M., & Merlo, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0442-z · Cited by 91
Levitt, R. J., Georgescu, M.-M., & Pollak, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.229 · Cited by 90
Towards systematic functional characterization of cancer genomes
Boehm, J. S., & Hahn, W. C. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3013 · Cited by 90
Self-citationGuanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
Li, M., Mukasa, A., Inda, M. D. M., Zhang, J., Chin, L., Cavenee, W. K., & Furnari, F. B. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20111102 · Cited by 90
Self-citationSerum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
IWAMOTO, F. M., Hottinger, A. F., Karimi, S., Riedel, E., Dantis, J., Jahdi, M., Panageas, K., Lassman, A. B., Abrey, L. E., Fleisher, M., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor117 · Cited by 89
Capper, D., Simon, M., Langhans, C., Okun, J. G., Tonn, J. C., Weller, M., von Deimling, A., Hartmann, C. J., & for the German Glioma Network (2011) · International Journal of Cancer · doi:10.1002/ijc.26425 · Cited by 86
Sensing invasion: Cell surface receptors driving spreading of glioblastoma
Teodorczyk, M., & Martín-Villalba, A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21901 · Cited by 85
PDGF stimulates the massive expansion of glial progenitors in the neonatal forebrain
Assanah, M. C., Bruce, J. N., Suzuki, S. O., Chen, A., Goldman, J. E., & Canoll, P. (2009) · Glia · doi:10.1002/glia.20895 · Cited by 83
Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
Jhanwar-Uniyal (2009) · International Journal of Oncology · doi:10.3892/ijo_00000386 · Cited by 83
Nabeshima, K., Shimao, Y., Sato, S., Kataoka, H., MORIYAMA, T., Kawano, H., Wakisaka, S., & Koono, M. (1997) · Histopathology · doi:10.1046/j.1365-2559.1997.3010889.x · Cited by 82
Dai, B., Pieper, R. O., Li, D., Wei, P., Liu, M., Woo, S. Y., Aldape, K., Sawaya, R. A., Xie, K., & Huang, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3909 · Cited by 80
Early Accelerated Approval for Highly Targeted Cancer Drugs
Chabner, B. A. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1100548 · Cited by 79
Banerjee, S., Byrd, J. N., Gianino, S. M., Harpstrite, S. E., Rodríguez, F. J., Tuskan, R. G., Reilly, K. M., Piwnica-Worms, D. R., & Gutmann, D. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2178 · Cited by 79
Fomchenko, E. I., Dougherty, J. D., Helmy, K. Y., Katz, A. M., Pietras, A., Brennan, C., Huse, J. T., Milosevic, A., & Holland, E. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020605 · Cited by 77
Self-citationSandsmark, D. K., Zhang, H., Hegedűs, B., Pelletier, C. L., Weber, J. D., & Gutmann, D. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4470 · Cited by 74
Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models
Lim, S. K., Llaguno, S. R. A., McKay, R. M., & Parada, L. F. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.3.158 · Cited by 72
Girdin maintains the stemness of glioblastoma stem cells
Natsume, A., Kato, T., Kinjo, S., Enomoto, A., Toda, H., Shimato, S., Ohka, F., Motomura, K., Kondo, Y., Miyata, T., et al. (2011) · Oncogene · doi:10.1038/onc.2011.466 · Cited by 70
Sahm, F., Capper, D., Pusch, S., Balß, J., Koch, A., Langhans, C., Okun, J. G., & von Deimling, A. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00506.x · Cited by 67
Erratum: Girdin maintains the stemness of glioblastoma stem cells
Natsume, A., Kato, T., Kinjo, S., Enomoto, A., Toda, H., Shimato, S., Ohka, F., Motomura, K., Kondo, Y., Miyata, T., et al. (2017) · Oncogene · doi:10.1038/onc.2017.17 · Cited by 66
EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts
Lal, B., Goodwin, C. R., Sang, Y., Foss, C. A., Cornet, K., Muzamil, S., Pomper, M. G., Kim, J., & Laterra, J. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0188 · Cited by 65
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.
Dunn, G. P., Dunn, I. F., & Curry, W. T. (2007) · PubMed · Cited by 64
Self-citationGenomic changes in progression of low-grade gliomas
Idbaïh, A., Silva, R. C., Crinière, E., Marie, Y., Carpentier, C., Boisselier, B., Taillibert, S., Rousseau, A., Mokhtari, K., Ducray, F., et al. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9644-z · Cited by 60
Brennan, C. (2011) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-011-0198-7 · Cited by 58
Self-citationUsing Mice to Decipher the Molecular Genetics of Brain Tumors
Hesselager, G., & Holland, E. C. (2003) · Neurosurgery · doi:10.1227/01.neu.0000081304.57547.b5 · Cited by 55
Modeling oncogene addiction using RNA interference
Rothenberg, S. M., Engelman, J. A., Le, S., Riese, D. J., Haber, D. A., & Settleman, J. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803217105 · Cited by 49
Change in Pattern of Relapse After Antiangiogenic Therapy in High-Grade Glioma
Narayana, A., Kunnakkat, S., Medabalmi, P., Golfinos, J. G., Parker, E. C., Knopp, E. A., Zagzag, D., Eagan, P., Gruber, D., & Gruber, M. L. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.038 · Cited by 49
Stockhausen, M., Broholm, H., Villingshøj, M., Kirchhoff, M., Gerdes, T., Kristoffersen, K., Kosteljanetz, M., Spang‐Thomsen, M., & Poulsen, H. S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.04.001 · Cited by 48
Panner, A., Crane, C. A., Weng, C., Feletti, A., Parsa, A. T., & Pieper, R. O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1287 · Cited by 48
Antiangiogenic Therapy in Malignant Glioma: Promise and Challenge
Sathornsumetee, S., & Rich, J. N. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207782794130 · Cited by 47
Seeing is Believing: Are Cancer Stem Cells the Loch Ness Monster of Tumor Biology?
Lathia, J. D., Venere, M., Rao, M. S., & Rich, J. N. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9194-6 · Cited by 46
Lopez, K. A., Tannenbaum, A. M., Assanah, M. C., Linskey, K. R., Yun, J. J., Kangarlu, A., Gil, O. D., Canoll, P., & Bruce, J. N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0906 · Cited by 43
Paternot, S., & Roger, P. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3260 · Cited by 42
Migration and fate of therapeutic stem cells in different brain disease models
Carney, B. J., & Shah, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.063 · Cited by 41
A Case of Ollierʼs Disease Associated with Two Intracranial Gliomas
Rawlings, C. E., Bullard, D. E., Burger, P. C., & Friedman, A. H. (1987) · Neurosurgery · doi:10.1227/00006123-198709000-00023 · Cited by 35
Rodin, S. N., & Rodin, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11927 · Cited by 34
Desai, S., Pillai, P., Win-Piazza, H., & Acevedo-Duncan, M. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.007 · Cited by 32
Genomics of Acute Myeloid Leukemia
Graubert, T. A., & Mardis, E. R. (2011) · The Cancer Journal · doi:10.1097/ppo.0b013e31823c5652 · Cited by 25
Animal models to study cancer-initiating cells from Glioblastoma
Wee, B. (2011) · Frontiers in bioscience · doi:10.2741/3851 · Cited by 21
Cellular Origins of Malignant Glioma: The Cancer Stem Cell Polemic
Taylor, C. M., Sauvageot, C., Wen, P. Y., & Stiles, C. D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-166-0_3 · Cited by 3
(2003) · PubMed
Cited by
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
“Although reported median survival for patients with GBM ranges from 12–18 months, a subset of individuals will survive for more than 3 years (Dolecek et al., 2012; Dunn et al., 2012).”
BackgroundSelf-citationCSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Self-citationWang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
Self-citationDNA Nanotechnology-Enabled Drug Delivery Systems
Hu, Q., Li, H., Wang, L., Gu, H., & Fan, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00663 · Cited by 1,118
Glioblastoma: pathology, molecular mechanisms and markers
Aldape, K., Zadeh, G., Mansouri, S., Reifenberger, G., & von Deimling, A. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1432-1 · Cited by 735
Metadata
- Authors
- Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., Brennan, C., Ligon, K. L., Furnari, F., Cavenee, W. K., Depinho, R. A., Chin, L., & Hahn, W. C.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2012-04-15
- Volume
- 26
- Issue
- 8
- Pages
- 756-784
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2166798417
- Cited by
- 565
- References
- 352
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.